Amprenavir-Impurities | Pharmaffiliates

amprenavir and its Impurities

Amprenavir was patented in 1992 and approved for medical use in 1999.It inhibitor used to treat HIV infection. Reference standards of Amprenavir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 5 results for amprenavir Impurities
PA 28 93000

Amprenavir - API

Amprenavir


  • Catalogue No.:PA 28 93000

  • CAS :

    161814-49-9

  • Molecular Formula : C25H35N3O6S

  • Molecular Weight : 505.63

PA STI 007650

Amprenavir-d4

Amprenavir-d4


  • Catalogue No.:PA STI 007650

  • CAS :

    1217661-20-5

  • Molecular Formula : C25H31D4N3O6S

  • Molecular Weight : 509.65

PA STI 011510

[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl[(4-nitro-phenyl)sulfonyl)]amino]propyl]-carbamic Acid tert-Butyl Ester

[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl[(4-nitro-phenyl)sulfonyl)]amino]propyl]-carbamic Acid tert-Butyl Ester


  • Catalogue No.:PA STI 011510

  • CAS :

    191226-98-9

  • Molecular Formula : C25H35N3O7S

  • Molecular Weight : 521.63

PA STI 011520

[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-d9-[(4-nitrophenyl)sulfonyl]amino] propyl]carbamic Acid tert-Butyl Ester

[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-d9-[(4-nitrophenyl)sulfonyl]amino] propyl]carbamic Acid tert-Butyl Ester


  • Catalogue No.:PA STI 011520

  • CAS :

    NA

  • Molecular Formula : C25H26D9N3O7S

  • Molecular Weight : 530.68

PA 28 93510

[(1S,2R)-3-[[(4-Nitrophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic Acid, (3S)-Tetrahydro-3-furanyl Ester

[(1S,2R)-3-[[(4-Nitrophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic Acid, (3S)-Tetrahydro-3-furanyl Ester


  • Catalogue No.:PA 28 93510

  • CAS :

    160231-69-6

  • Molecular Formula : C25H33N3O8S

  • Molecular Weight : 535.61